Related Experiment Video
Updated: Jun 24, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
Rational biosynthetic engineering for optimization of geldanamycin analogues
Woncheol Kim1, Dongho Lee, Seong Su Hong
1Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Korea.
Researchers engineered geldanamycin analogues with improved anticancer properties. Site-directed mutagenesis of the polyketide synthase (PKS) and tailoring genes created novel derivatives, like DHQ3, showing enhanced Hsp90 inhibition and potential for better chemotherapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Geldanamycin and its derivatives are potential anticancer agents targeting Hsp90.
- First-generation Hsp90 inhibitors exhibit reduced efficacy and toxicity.
- Optimization of geldanamycin's pharmacological profile is crucial for clinical application.
Purpose of the Study:
- To rationally design and biosynthesize novel geldanamycin analogues with improved pharmacological properties.
- To overcome the limitations of existing geldanamycin-based therapies.
Main Methods:
- Site-directed mutagenesis of the geldanamycin polyketide synthase (PKS).
- Introduction of post-PKS tailoring genes.
- Biosynthesis of C15 hydroxylated non-quinone geldanamycin analogues.
Main Results:
- Generation of geldanamycin derivatives, including DHQ3.
- DHQ3 demonstrated 4.6-fold stronger inhibition of Hsp90 ATPase activity than geldanamycin.
- The engineered analogues exhibited superior pharmacological properties compared to the parent compound.
Conclusions:
- Rational biosynthetic engineering is an effective strategy for optimizing geldanamycin derivatives.
- The developed analogues hold promise for enhanced anticancer chemotherapy.
- DHQ3 represents a significant advancement in Hsp90 inhibitor development.
More Related Videos
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
Related Concept Videos
Bioreactor Controls-III
Production of Pharmaceuticals
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Inhibitors of Bacterial Protein Synthesis